CNS Therapeutics Markets, 2016-2024 - Global Strategic Business Report 2017

Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants & Others - Seite 3

Market Overview
Anti-Depressant Treatment
Low R&D Investments Restrict New Antidepressants Development
Select Antidepressants Drugs
Zoloft (Sertraline)
Cymbalta
Prozac (Fluoxetine)
Effexor (Venlafaxine)
Paxil
Wellbutrin (Bupropion)
Anti-Psychotics
Market Overview
Companies Focus on Next Generation Products to Deflect the Heat of Competition
Leading Atypical Antipsychotics for the Treatment of Schizophrenia
Promising Compounds in Clinical Development for the Treatment of Schizophrenia in Adults
Select Anti-Psychotic Drugs
Zyprexa
Seroquel
Abilify
Clozaril
Risperdal
Risperdal Consta
Geodon
Invega Sustenna
Saphris
Latuda
Other CNS Disorders (ADHD, MS, and Insomnia)
Attention Deficit Hyperactivity Disorder (ADHD)
Market Overview
Approved Drugs for ADHD: 2017
Pipeline Drugs for ADHD: As of March 2017
Select ADHD Drugs
Concerta
Adderall
Multiple Sclerosis (MS)
Multiple Sclerosis Approved Therapies (Injectables)
Multiple Sclerosis Approved Therapies (Oral)
Patent Expiration Date/Year of the Major MS Drugs
Ocrevus
The First Approved Drug for Primary Progressive Multiple Sclerosis (PPMS)
Multiple Sclerosis: Pipeline Analysis
Potential MS treatments, which are currently in Phase 3 Clinical Trials
Potential MS treatments, which are currently in Phase 2 Clinical Trials
Potential Treatment for Primary Progressive MS, which are in Phase 3
Potential Treatment for Primary Progressive MS, which are in Phase 2
Potential Treatment for Secondary Progressive MS, which are in Phase 3
Potential Treatment for Secondary Progressive MS, Which are in Phase 2
Insomnia
Overview
Zolpidem
Eszopiclone

3. GROWTH DRIVERS & MARKET TRENDS
Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Increased Spending on Prescription Drugs Bodes Well for the CNS Therapeutics Market
Rising Healthcare Expenditure to Boost CNS Therapeutics Market
Growing Penetration of Generic Drugs Emerges as a Key Trait
Developments in CNS Drug Delivery Technologies Bode Well for the CNS Drugs Market
Understanding of BBB Cell Biology & Its Positive Impact on Epilepsy Drugs: A Case-in-Point
Pharma Companies: Seeking New Tools to Offset Pressure on Drug Pipelines
Awareness Campaigns Launched by Pharma Companies to Benefit the Market
Music and Memory Programs Positively Impact Alzheimer's Disease (AD) and Related Dementia (ADRD) Patients
New Method to Isolate Active Compounds Related to Alzheimers from Plant Medicines